On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,315 KRW | +10.24% | +9.72% | -29.53% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,370 KRW | -1.70% | -2.15% | 71.9M | ||
3,245 KRW | +0.62% | -3.99% | 523M | ||
2,315 KRW | +10.24% | +9.72% | 40.97M | ||
2,080 KRW | +0.73% | +3.48% | 80.07M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.53% | 40.97M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors